Organization
Advaxis, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Advaxis, Inc.
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization ...
... in the biopharmaceutical industry, including CEO and other executive leadership positions at Advaxis, Inc., ImClone Systems, Bracco Diagnostics, Inc., and PharmaNet (today, inVentiv Health). Most ...
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization ...
... cancer, breast cancer, and prostate cancer. Regen Biopharma, Inc. (OTC: RGBP), Advaxis, Inc. (NASDAQ: ADXS), OncoSec Medical Incorporated (NASDAQ: ONCS), Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), ...
... If you want a Stock Review on AGEN, AKBA, ACOR, or ADXS then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report. Today, ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and ...
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization ...
... Advaxis, Inc . (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and ...
... If you want a Stock Review on ACOR, ADXS, XBIT, or AKBA then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization ...
... a more advanced approach based on data, computer modeling and simulation. FierceBiotech ​​​​Advaxis ImmunotherapiesDaniel O’Connor stepped down. Daniel O’Connor, Advaxis’ CEO since 2013, has resigned ...
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization ...
... BioTech Inc, Advanced Accelerator Applications SA, Advanced Cancer Therapeutics LLC, Advantagene Inc, Advaxis Inc, Aeglea BioTherapeutics Inc, Aeolus Pharmaceuticals Inc, Aeterna Zentaris Inc, Akshaya Bio ...
... Daniel O’Connor has resigned as CEO of Advaxis. The cancer immunotherapy biotech has put CBO Tony Lombardo in charge while ...
... Daniel J. O'Connor, chief executive officer, president and board member of Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and ...
... Advaxis, Inc. has announced that the European Society of Gynaecologic Oncology (ESGO) has ...
... Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that the ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, held its annual ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that ...
... Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that ...
... breach of fiduciary duty claim involving the board of directors of Advaxis, Inc. (NASDAQ: ADXS). If you are a shareholder of Advaxis, Inc. and are ...
... Biosciences Inc. (NASDAQ: CALA), Five Prime Therapeutics Inc. (NASDAQ: FPRX), and Advaxis Inc. (NASDAQ: ADXS). According to a Zacks report, a key concern for the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤